Global Health Ltd

Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Global Health Ltd

₹ 1,183 -1.12%
12 Jun 3:17 p.m.
medanta.org BSE: 543654 NSE: MEDANTA
About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Key Points

Hospital Count[1] Global Health operates five hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, and Patna, with one more hospital under construction in Noida. The company provides services in over 30 medical specialties, employing 1,750+ doctors across a total area of 4.7 million square feet.
The operational hospitals have 3,008 installed beds. In addition, Global Health runs 6 multi-specialty clinics in locations such as DLF Cybercity Gurugram, Delhi Airport, South Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]

Website BSE NSE
  • Market Cap ₹ 31,773 Cr.
  • Current Price ₹ 1,183
  • High / Low ₹ 1,389 / 936
  • Stock P/E 63.7
  • Book Value ₹ 130
  • Dividend Yield 0.00 %
  • ROCE 20.7 %
  • ROE 15.7 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 37.1% CAGR over last 5 years

Cons

  • Stock is trading at 9.22 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
411 473 494 490 506 551 580 565 724 611 665 812 803
344 372 391 394 400 435 452 439 560 479 514 611 608
Operating Profit 67 101 103 95 106 115 128 126 164 132 150 202 195
OPM % 16% 21% 21% 19% 21% 21% 22% 22% 23% 22% 23% 25% 24%
12 8 13 13 25 27 26 23 30 27 24 19 -24
Interest 6 7 7 6 6 6 6 6 10 6 5 8 7
Depreciation 22 22 22 22 20 20 22 22 35 23 25 37 38
Profit before tax 51 80 87 80 104 116 127 121 149 130 144 175 126
Tax % 25% 27% 25% 26% 22% 26% 25% 28% 26% 26% 27% 25% 26%
38 58 65 59 81 86 95 87 109 96 104 131 93
EPS in Rs 1.50 2.30 2.58 2.19 3.02 3.21 3.54 3.25 4.08 3.59 3.89 4.89 3.48
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,277 1,343 1,441 1,472 1,227 1,765 1,974 2,280 3,204
1,158 1,218 1,297 1,253 1,054 1,384 1,551 1,777 2,439
Operating Profit 119 125 144 219 173 381 423 503 765
OPM % 9% 9% 10% 15% 14% 22% 21% 22% 24%
67 49 64 43 28 35 47 103 41
Interest 19 24 21 33 29 33 32 30 33
Depreciation 77 86 91 99 88 87 86 87 150
Profit before tax 89 64 97 131 84 296 352 489 623
Tax % 39% 42% 35% 22% 32% 26% 25% 26% 26%
54 37 63 103 57 219 263 361 462
EPS in Rs 11.21 7.70 12.81 20.82 11.55 8.64 9.82 13.44 17.18
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 3%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 22%
TTM: 41%
Compounded Profit Growth
10 Years: %
5 Years: 37%
3 Years: 32%
TTM: 38%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -4%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 14%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 48 81 49 49 50 51 54 54 54
Reserves 1,070 1,141 1,230 1,341 1,434 1,689 2,435 2,795 3,444
215 168 168 51 228 308 288 260 223
303 318 310 517 291 314 402 414 720
Total Liabilities 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,523 4,441
966 1,162 869 929 851 827 810 841 1,865
CWIP 8 7 5 3 4 6 75 184 454
Investments 21 0 356 500 626 734 765 790 366
642 540 528 525 521 794 1,529 1,708 1,757
Total Assets 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,523 4,441

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
124 152 193 201 235 431 341 528
-112 -104 -45 -250 -313 -257 -699 -638
-6 -49 -56 -37 98 404 -66 -94
Net Cash Flow 6 -1 92 -86 20 577 -424 -205

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 41 42 37 39 36 32 31 33
Inventory Days 36 26 26 37 39 33 34 30 24
Days Payable 132 124 142 135 134 84 113 93 81
Cash Conversion Cycle -66 -56 -74 -61 -56 -16 -48 -32 -24
Working Capital Days -23 -4 -7 -11 -10 8 -13 -1 -8
ROCE % 6% 8% 11% 7% 17% 16% 18% 21%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
33.08% 33.08% 33.07% 33.06% 33.05% 33.04% 33.04% 33.04% 33.03% 33.03%
9.36% 9.89% 10.58% 10.69% 11.36% 12.10% 12.94% 12.21% 12.48% 11.76%
12.55% 12.34% 10.79% 10.93% 11.15% 10.25% 10.57% 11.11% 10.51% 11.93%
45.01% 44.67% 45.55% 45.31% 44.45% 44.60% 43.44% 43.64% 43.98% 43.28%
No. of Shareholders 1,21,4071,07,1201,09,7981,16,6271,24,7751,66,2531,55,3071,49,7221,48,6331,54,688

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls